NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 142 filers reported holding NEOGENOMICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,775,000 | +3.9% | 207,075 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,708,000 | +2.3% | 207,729 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $1,669,000 | +29.1% | 207,594 | +8.2% | 0.00% | 0.0% |
| Q1 2016 | $1,293,000 | -12.8% | 191,820 | +1.9% | 0.00% | 0.0% |
| Q4 2015 | $1,482,000 | +38.4% | 188,256 | +0.7% | 0.00% | +100.0% |
| Q3 2015 | $1,071,000 | +7.7% | 186,869 | +1.7% | 0.00% | 0.0% |
| Q2 2015 | $994,000 | +3006.2% | 183,761 | +2561.7% | 0.00% | – |
| Q1 2015 | $32,000 | +14.3% | 6,904 | +3.2% | 0.00% | – |
| Q4 2014 | $28,000 | -20.0% | 6,693 | 0.0% | 0.00% | – |
| Q3 2014 | $35,000 | +94.4% | 6,693 | +20.7% | 0.00% | – |
| Q2 2014 | $18,000 | -94.4% | 5,546 | -94.0% | 0.00% | – |
| Q1 2014 | $323,000 | -3.3% | 93,116 | +1.0% | 0.00% | – |
| Q4 2013 | $334,000 | +21.0% | 92,169 | +0.3% | 0.00% | – |
| Q3 2013 | $276,000 | -14.3% | 91,881 | +13.7% | 0.00% | -100.0% |
| Q2 2013 | $322,000 | – | 80,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,291,019 | $22,477 | 12.11% |
| Greenhouse Funds LLLP | 2,930,014 | $51,011,544 | 4.27% |
| First Light Asset Management, LLC | 2,698,958 | $46,988,859 | 4.23% |
| PERKINS CAPITAL MANAGEMENT INC | 197,000 | $3,430 | 3.23% |
| Altium Capital Management LP | 240,000 | $4,178,400 | 2.32% |
| FORMULA GROWTH LTD | 280,690 | $4,886,813 | 1.57% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 101,065 | $1,759,542 | 1.42% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,374,783 | $23,934,972 | 1.41% |
| EMERALD ADVISERS, LLC | 1,669,324 | $29,062,931 | 1.39% |
| Lisanti Capital Growth, LLC | 528,235 | $9,196,571 | 1.28% |